Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenax Therapeutics (TENX) Profit After Tax (2016 - 2026)

Tenax Therapeutics' Profit After Tax history spans 7 years, with the latest figure at -$16.3 million for Q4 2017.

  • On a quarterly basis, Profit After Tax rose 71.93% to -$16.3 million in Q4 2017 year-over-year; TTM through Dec 2017 was -$8.8 million, a 83.82% increase, with the full-year FY2025 number at -$52.6 million, down 198.86% from a year prior.
  • Profit After Tax hit -$16.3 million in Q4 2017 for Tenax Therapeutics, down from $1.2 million in the prior quarter.
  • Over the last five years, Profit After Tax for TENX hit a ceiling of $4.6 million in Q2 2016 and a floor of -$58.2 million in Q4 2016.
  • Historically, Profit After Tax has averaged -$6.6 million across 4 years, with a median of -$2.4 million in 2013.
  • The widest YoY moves for Profit After Tax: up 246.33% in 2016, down 478.08% in 2016.
  • Tracing TENX's Profit After Tax over 4 years: stood at -$1.9 million in 2013, then tumbled by 441.57% to -$10.1 million in 2015, then tumbled by 478.08% to -$58.2 million in 2016, then soared by 71.93% to -$16.3 million in 2017.
  • Business Quant data shows Profit After Tax for TENX at -$16.3 million in Q4 2017, $1.2 million in Q3 2017, and $3.0 million in Q2 2017.